Immunex Novantrone Proposed Labeling For MS Indication
Executive Summary
"Novantrone is indicated for the treatment of patients with secondary progressive multiple sclerosis, including progressive relapsing disease. Novantrone has been shown to slow the progression of physical disability and neurologic impairment, reduce the frequency of clinical relapse, increase the time to the first treated relapse, and reduce the number of hospitalizations.